Prognostic impact of ezrin expression in Ewing sarcoma.

被引：0
|
作者：
Cash, Thomas
Yin, Hong
McCracken, Courtney
Geng, Zhi
DuBois, Steven G.
Shehata, Bahig M.
Olson, Thomas Arthur
Katzenstein, Howard M.
Wetmore, Cynthia
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Childrens Healthcare Atlanta, Atlanta, GA USA
[3] Dana Farber, Boston Childrens Canc & Blood Disorders Ctr, Boston, MA USA
[4] Vanderbilt Univ, Ingram Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.10545
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10545
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Dose escalation of doxorubicin hydrochloride and ifosfamide in previously untreated Ewing sarcoma.
    Memon, Muhammad
    Raja, Madras A.
    Ahmad, Javed
    Pant, Rajive
    Shaheen, Mahmoud
    Al-Dayel, Fouad
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Long-term outcome of patients with lower extremity Ewing sarcoma.
    Ranft, Andreas
    Winter, Corinna
    Hoffmann, Christiane
    Rosenbaum, Dieter
    Rossig, Claudia
    Juergens, Herbert
    Dirksen, Uta
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05)
  • [33] Prognostic indicators for Ewing's sarcoma
    Tageja, Nishant
    LANCET, 2010, 376 (9737): : 232 - 232
  • [34] Bmi-1 functions as a cooperative oncogene in Ewing's sarcoma.
    Douglas, Dorothea N.
    Peng, Grace
    Hung, Long
    Somanchi, Srinivas Sai
    Triche, Timothy J.
    May, William A.
    Lawlor, Elizabeth R.
    CANCER RESEARCH, 2006, 66 (08)
  • [35] Genomic co-genotype classification and clinical prognosis in Ewing sarcoma.
    You, Yang
    Guo, Xi
    Zhuang, Rongyuan
    Li, Wei
    Zhang, Chenlu
    Wang, Zhiming
    Shen, Feng
    Zhou, Qiwen
    Song, Zhengqing
    Zhang, Yong
    Lu, Weiqi
    Jiang, Zhengzeng
    Zhou, Xiaoyu
    Sun, Ying
    Zhou, Yuhong
    Ji, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Expression of MYCN and MRP in synovial sarcoma.
    Chan, S
    Zielenska, M
    Fabricius, N
    Sun, P
    Thorner, PS
    MODERN PATHOLOGY, 2001, 14 (01) : 1P - 1P
  • [37] Value of local treatment modalities in patients with localized Ewing Sarcoma. Report from the Ewing 2008 trial
    Heesen, Philip
    Ranft, Andreas
    Bhadri, Vivek
    Brichard, Benedicte
    Collaud, Stephane
    Cyprova, Sona
    Eich, Hans
    Ek, Torben
    Gelderblom, Hans
    Hardes, Jendrik
    Haveman, Lianne
    Hartmann, Wolfgang
    Hauser, Peter
    Jurgens, Heribert
    Kanerva, Jukka
    Kuehne, Thomas
    Raciborska, Anna
    Rascon, Jelena
    Streitbuerger, Arne
    Timmermann, Beate
    Uhlenbruch, Yasmine
    Dirksen, Uta
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 233 - 233
  • [38] Xg Expression in Ewing's Sarcoma Is of Prognostic Value and Contributes to Tumor Invasiveness
    Meynet, Ophelie
    Scotlandi, Katia
    Pradelli, Emmanuelle
    Manara, Maria C.
    Colombo, Mario P.
    Schmid-Antomarchi, Heidy
    Picci, Piero
    Bernard, Alain
    Bernard, Ghislaine
    CANCER RESEARCH, 2010, 70 (09) : 3730 - 3738
  • [39] Loss of MTAP expression is a negative prognostic marker in Ewing sarcoma family of tumors
    Abrahao-Machado, Lucas Faria
    Antunes, Bruno
    Filippi, Renee Zon
    Volc, Sahlua
    Boldrini, Erica
    Menezes, Weder P.
    Reis, Rui M.
    de Camargo, Olavo Pires
    BIOMARKERS IN MEDICINE, 2018, 12 (01) : 35 - 44
  • [40] Progress towards development of an exosome-based biomarker assay in Ewing sarcoma.
    Samuel, Glenson
    Crow, Jennifer
    Atay, Safinur
    Godwin, Andrew K.
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 28 - 29
12345